Mapel DW - Search Results

1

Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease.

Roberts MH, Mapel DW, Bruse S, Petersen H, Nyunoya T. Roberts MH, et al. Among authors: mapel dw. Am J Epidemiol. 2013 Oct 1;178(7):1150-60. doi: 10.1093/aje/kwt087. Epub 2013 Aug 8. Am J Epidemiol. 2013. PMID: 23928262 Free PMC article.

2

Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization.

Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Mapel DW, et al. Arch Intern Med. 2000 Sep 25;160(17):2653-8. doi: 10.1001/archinte.160.17.2653. Arch Intern Med. 2000. PMID: 10999980

3

Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.

Mapel DW, Hurley JS, Roblin D, Roberts M, Davis KJ, Schreiner R, Frost FJ. Mapel DW, et al. Respir Med. 2006 Apr;100(4):595-609. doi: 10.1016/j.rmed.2005.08.006. Epub 2005 Sep 30. Respir Med. 2006. PMID: 16199151 Free article.

4

An algorithm for the identification of undiagnosed COPD cases using administrative claims data.

Mapel DW, Frost FJ, Hurley JS, Petersen H, Roberts M, Marton JP, Shah H. Mapel DW, et al. J Manag Care Pharm. 2006 Jul-Aug;12(6):457-65. J Manag Care Pharm. 2006. PMID: 16925453

5

Can outpatient pharmacy data identify persons with undiagnosed COPD?

Mapel DW, Petersen H, Roberts MH, Hurley JS, Frost FJ, Marton JP. Mapel DW, et al. Am J Manag Care. 2010 Jul;16(7):505-12. Am J Manag Care. 2010. PMID: 20645666 Free article. Clinical Trial.

6

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.

Dalal AA, Roberts MH, Petersen HV, Blanchette CM, Mapel DW. Dalal AA, et al. Among authors: mapel dw. Int J Chron Obstruct Pulmon Dis. 2010 Dec 31;6:13-22. doi: 10.2147/COPD.S15455. Int J Chron Obstruct Pulmon Dis. 2010. PMID: 21311689 Free PMC article.

7

Economic burden of chronic bronchitis in the United States: a retrospective case-control study.

Blanchette CM, Roberts MH, Petersen H, Dalal AA, Mapel DW. Blanchette CM, et al. Among authors: mapel dw. Int J Chron Obstruct Pulmon Dis. 2011 Jan 13;6:73-81. doi: 10.2147/COPD.S15882. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 21311695 Free PMC article.

8

Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD management.

Roberts M, Mapel D, Petersen H, Blanchette C, Ramachandran S. Roberts M, et al. J Med Econ. 2011;14(6):769-76. doi: 10.3111/13696998.2011.622817. Epub 2011 Sep 27. J Med Econ. 2011. PMID: 21942463 Free article.

9

Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims.

Mapel DW, Dalal AA, Blanchette CM, Petersen H, Ferguson GT. Mapel DW, et al. Int J Chron Obstruct Pulmon Dis. 2011;6:573-81. doi: 10.2147/COPD.S16975. Epub 2011 Nov 9. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 22135490 Free PMC article.

10

Limited lung function: impact of reduced peak expiratory flow on health status, health-care utilization, and expected survival in older adults.

Roberts MH, Mapel DW. Roberts MH, et al. Among authors: mapel dw. Am J Epidemiol. 2012 Jul 15;176(2):127-34. doi: 10.1093/aje/kwr503. Epub 2012 Jun 28. Am J Epidemiol. 2012. PMID: 22759722 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters